MobiHealth News June 25, 2025
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
ForSight Robotics, a company developing a robot to assist with ophthalmic surgery, announced it secured $125 million in a Series B funding round led by Eclipse, bringing the company’s total raise to $195 million.
Reiya Ventures, Adani Group and other existing investors participated in the round. Dr. Fred Moll, founder of Intuitive Surgical and the da Vinci surgical system, also participated.
ForSight Robotics also said it received significant participation in the round from an unnamed strategic investor.
WHAT IT DOES
The Israel-based company is developing ORYOM Platform, a surgical robot...
Today's Sponsors
Today's Sponsor